Anika to Participate in the Sidoti Spring Virtual Investor Conference

Rhea-AI Summary

Anika Therapeutics, a joint preservation company, will present at the Sidoti Spring Virtual Investor Conference on March 25, 2021, at 8:30 a.m. ET. The presentation will feature Dr. Cheryl Blanchard, President and CEO, alongside Michael Levitz, Executive Vice President and CFO. A live audio webcast will be available on Anika’s website, with an archive accessible later. Anika focuses on innovative orthopedic solutions, including osteoarthritis management and regenerative treatments.

News Market Reaction – ANIK

+3.93%

+3.93% Session move

In the trading session that priced this news, ANIK gained 3.93%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present at the Sidoti Spring Virtual Investor Conference on Thursday, March 25, 2021 at 8:30 a.m. ET.

A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the session will also be available on the website.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe. For more information about Anika, please visit www.anika.com.

For Investor Inquiries:
Mark Namaroff
Anika Therapeutics, Inc.
Executive Director, Investor Relations and Corporate Communications
Direct: 781-457-9287
mnamaroff@anika.com

FAQ

When is Anika Therapeutics presenting at the Sidoti Spring Virtual Investor Conference?

Anika Therapeutics will present at the Sidoti Spring Virtual Investor Conference on March 25, 2021, at 8:30 a.m. ET.

Who will represent Anika Therapeutics at the investor conference?

Dr. Cheryl Blanchard, President and CEO, and Michael Levitz, Executive Vice President and CFO, will represent Anika Therapeutics.

Where can I watch Anika Therapeutics' conference presentation live?

The presentation will be live-streamed on Anika Therapeutics' Investor Relations section of their website.

Will there be a recording of Anika's presentation at the conference?

Yes, an audio archive of Anika's presentation will be available on their website after the event.

What is Anika Therapeutics' focus in the orthopedic market?

Anika Therapeutics specializes in joint preservation and offers solutions for osteoarthritis management and regenerative treatments.